Eko Rianova Lynoora, Rahmadewi Rahmadewi

Abstract views = 1271 times | downloads = 1989 times


Sezary syndrome is the leukemic variant of cutaneous T cell lymphoma. This disease is characterized by some reddish patches or plaques all over the skin which extends to the whole body into erythroderma, lymphadenopathy. It is also indicated by the presence of atypical lymphocytes called Sezary cells. This case report is aimed to know clinical manifestation, examination and management of Sezary syndrome which clinically resembles generalized psoriasis. A 60 years old man came with scaly reddish brown plaques almost all over his body. It was accompanied by lymphadenopathy on the supraclavicular lymph node right and left as well as intense itchy. Other clinical features were alopecia, palmoplantar hyperkeratosis, onychodysthropy, facies leonine without anesthesia on the lesion and enlargement of peripheral nerve. From a laboratory test, an increase in the number of leukocytes and, Sezary cells were found in peripheral blood smear examination; while the histopathology showed focal athrophy and acanthosis of the epidermis and dense infiltration of lymphocytes in the dermo-epidermal junction and superficial dermis. Patient received 3 x 5 mg (1 cycle) of methotrexate (MTX) with 0,1% cream mometasone furoate and 3x1 tablet of CTM for adjunctive therapy. Methotrexate was discontinued because there was a disturbance in liver function and deterioration of patient’s condition. After 25 days of treatment, the patient got sepsis and then passed away. Early onset of Sezary syndrome in this case is difficult to know because the clinical manifestation is similar with psoriasis vulgaris. Supporting examination such as laboratory test, blood smears and histopathology examination could help the diagnosis. The presence of lymphadenopathy, and atypical lymphocytes in the peripheral blood and the extensive skin involvement reflect the poor prognosis. The most common cause of death was sepsis.


Sezary syndrome; cutaneous T cell lymphoma; psoriasis vulgaris; erythroderma; Sezary cells

Full Text:



H KY. Cutaneous T-cell Lymphoma Facts. Leukemia and Lymphoma Society; 2011. 1-9 p.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2.

Hwang ST, Janik JE, Jaffe ES, Wilson WH. Mycosis fungoides and Sézary syndrome. Lancet. 2008 Mar;371(9616):945–57.

Doukaki S, Aricò M, Bongiorno MR. A Rare Presentation of Mycosis Fungoides Mimicking Psoriasis Vulgaris. Case Rep Dermatol. 2009;1(1):60–5.

Cyriac MJ, Kurian A. Sézary cell. Indian J Dermatol Venereol Leprol. 2004;70(5):321–4.

Demierre M-F. Mycosis fungoides and Sézary syndrome: the burden of pruritus. Community Oncol. 2010 Sep;7(9):399–404.

Shaikha SA, Mansoor K, Homsi HA, Riad H. Sézary syndrome. Gulf J Dermatology Venerol. 2005 Apr;12(1):50–3.

Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, et al. Sézary Syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol. 2011 Feb;64(2):352–404.

Whittaker SJ, Marsden JR, Spittle M, Russell Jones R, British Association of Dermatologists, U.K. Cutaneous Lymphoma Group. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol. 2003 Dec;149(6):1095–107.

Pacheco D, Fraga A, Travassos AR, Antunes J, Freitas J, Soares de Almeida L, et al. Actinic reticuloid imitating Sézary syndrome. Acta dermatovenerologica Alpina, Pannonica, Adriat. 2012 Sep;21(3):55–7.

Yamashita T, Abbade LPF, Marques MEA, Marques SA. Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update. An Bras Dermatol. 2012 Dec;87(6):817–30.

Desar IME, Stevens WBC, Verweij PE, Velden WJFM van der. A Sezary Cryptogram. Netherlands J Med. 2011;69(1).

Zackheim HS, Epstein EH. Low-dose methotrexate for the Sézary syndrome. J Am Acad Dermatol. 1989 Oct;21(4 Pt 1):757–62.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2.

Mirvish ED, Pomerantz RG, Geskin LJ. Infectious agents in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2011 Feb;64(2):423–31.


  • There are currently no refbacks.

Copyright (c) 2017 Indonesian Journal of Tropical and Infectious Disease

View My Stats

IJTID Indexed by : 


IJTID (pISSN 2085-1103eISSN 2356-0991is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Lembaga Penyakit Tropis (Institute of Tropical Disease)

Universitas Airlangga

Kampus C Mulyorejo

Surabaya 60115